Recombinant multi-species TMEM27/CLTRN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TMEM27/CLTRN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a type 1 transmembrane protein that is important for trafficking amino acid transporters to the apical brush border of proximal tubules. The encoded protein binds to amino acid transporters and regulates their expression on the plasma membrane. It also plays a role in controlling insulin exocytosis by regulating formation of the SNARE (soluble N-ethylmaleimide-sensitive-factor attachment protein receptor) complex in pancreatic beta cells. The extracellular domain of the encoded protein may be cleaved and shed from the plasma membrane specifically in pancreatic beta cells. [provided by RefSeq, Jun 2013]
The Alternative Names of target: 0610008J07Rik,CLTRN,Cltrn,Collectrin,NX-17,NX17,Nx17,TMEM27,Tmem27,Transmembrane protein 27,collectrin

Target products collectionGo to TMEM27/CLTRN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10585-Ag-1/ GM-Tg-hg-IP10585-Ag-2 Human TMEM27/CLTRN protein Human
GM-Tg-rg-IP10585-Ag-1/ GM-Tg-rg-IP10585-Ag-2 Rat TMEM27/CLTRN protein Rat
GM-Tg-mg-IP10585-Ag-1/ GM-Tg-mg-IP10585-Ag-2 Mouse TMEM27/CLTRN protein Mouse
GM-Tg-cynog-IP10585-Ag-1/ GM-Tg-cynog-IP10585-Ag-2 Cynomolgus/Rhesus macaque TMEM27/CLTRN protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10585-Ag-1/ GM-Tg-felg-IP10585-Ag-2 Feline TMEM27/CLTRN protein Feline
GM-Tg-cang-IP10585-Ag-1/ GM-Tg-cang-IP10585-Ag-2 Canine TMEM27/CLTRN protein Canine
GM-Tg-bovg-IP10585-Ag-1/ GM-Tg-bovg-IP10585-Ag-2 Bovine TMEM27/CLTRN protein Bovine
GM-Tg-equg-IP10585-Ag-1/ GM-Tg-equg-IP10585-Ag-2 Equine TMEM27/CLTRN protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10585-Ag-1/ GM-Tg-hg-IP10585-Ag-2; GM-Tg-rg-IP10585-Ag-1/ GM-Tg-rg-IP10585-Ag-2;
GM-Tg-mg-IP10585-Ag-1/ GM-Tg-mg-IP10585-Ag-2; GM-Tg-cynog-IP10585-Ag-1/ GM-Tg-cynog-IP10585-Ag-2;
GM-Tg-felg-IP10585-Ag-1/ GM-Tg-felg-IP10585-Ag-2; GM-Tg-cang-IP10585-Ag-1/ GM-Tg-cang-IP10585-Ag-2;
GM-Tg-bovg-IP10585-Ag-1/ GM-Tg-bovg-IP10585-Ag-2; GM-Tg-equg-IP10585-Ag-1/ GM-Tg-equg-IP10585-Ag-2
Products Name TMEM27/CLTRN protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TMEM27/CLTRN
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TMEM27/CLTRN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.